Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.51 USD | +2.16% | -0.58% | +16.26% |
Financials (USD)
Sales 2024 * | 25.55M | Sales 2025 * | 70.34M | Capitalization | 361M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -46M | EV / Sales 2024 * | 14.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.13 x |
P/E ratio 2024 * |
-6.04
x | P/E ratio 2025 * |
-9.63
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.08% |
Latest transcript on Verrica Pharmaceuticals Inc.
1 day | +2.16% | ||
1 week | -0.58% | ||
1 month | +24.23% | ||
3 months | +53.33% | ||
6 months | +122.77% | ||
Current year | +16.26% |
Managers | Title | Age | Since |
---|---|---|---|
Ted White
CEO | Chief Executive Officer | 59 | 17-11-30 |
Terence Kohler
DFI | Director of Finance/CFO | 46 | 21-07-15 |
Compliance Officer | 60 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Prygocki
BRD | Director/Board Member | 58 | 18-04-30 |
Paul Manning
CHM | Chairman | 68 | 15-11-30 |
Craig Ballaron
BRD | Director/Board Member | 63 | 19-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.51 | +2.16% | 69,136 |
24-05-30 | 8.33 | -1.19% | 74,410 |
24-05-29 | 8.43 | +0.12% | 80,856 |
24-05-28 | 8.42 | -1.64% | 76,146 |
24-05-24 | 8.56 | +2.51% | 63,105 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.26% | 361M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- VRCA Stock